Publications by authors named "Chiara De Simone"

Article Synopsis
  • Glioblastoma multiforme (GBM) releases extracellular vesicles (EVs) that can transfer aggressive traits to other cells, making the study of these vesicles crucial for understanding tumor behavior.
  • * EV proteins are being investigated to find new biomarkers and targets for treatment, with proteomic studies primarily using "bottom-up" mass spectrometry on EVs from GBM cells and patient fluids.
  • * Despite identifying many dysregulated proteins, clinical translation is challenging due to inconsistent EV isolation methods and proteome analysis, highlighting the need for standardized techniques and exploring protein mutations to improve GBM therapies.*
View Article and Find Full Text PDF
Article Synopsis
  • The SNP rs4644 is a genetic change that affects a protein called galectin-3 (gal-3) and is linked to the risk of some cancers, including thyroid cancer.
  • Researchers studied two types of cells with different versions of this SNP to understand how it changes the proteins made by those cells.
  • They found that the SNP influences how gal-3 is formed and how it works, which might explain why some people are more likely to get certain diseases.
View Article and Find Full Text PDF

Triple negative breast cancer (TNBC) is a specific breast cancer subtype, and poor prognosis is associated to this tumour when it is in the metastatic form. The overexpression of the inducible Nitric Oxide Synthase (iNOS) is considered a predictor of poor outcome in TNBC patients, and this enzyme is reported as a valuable molecular target to compromise TNBC progression. In this work, new amidines containing a benzenesulfonamide group were designed and synthesized as selective iNOS inhibitors.

View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer disease (AD) is a complex age-related condition characterized by the formation of plaques and tangles in the brain, along with oxidative stress and inflammation; current treatments mainly focus on symptom management with limited success.
  • Recent research has shown that Oxotremorine-M (Oxo), a compound that activates certain acetylcholine receptors, can promote neuron health and combat oxidative stress and inflammation in the brain.
  • In laboratory testing on neuroblastoma cells exposed to harmful amyloid-beta peptide, Oxo treatment was found to improve cell survival, promote neurite growth, and protect against DNA damage, suggesting it could be a promising multi-target therapy for AD.
View Article and Find Full Text PDF

A 36-year-old man was admitted to the emergency department of "SS Annunziata" hospital in Chieti complaining of a sharp chest pain arisen some hours before admission. On examination, the patient looked sweaty; his vital signs showed tachycardia and augmented breath rate; sinus tachycardia and normal ventricular repolarization were observed on ECG, and no abnormalities were observed in the echoscan of the hearth. According to the clinical and electrocardiographic findings, and to previous episode of DVT in anamnesis, a thorax CT scan was performed in order to rule out pulmonary embolism.

View Article and Find Full Text PDF

A series of oxime carbamates have been identified as potent inhibitors of fatty acid amide hydrolase (FAAH), an important regulatory enzyme of the endocannabinoid signaling system. Kinetic analysis indicates that they behave as non-competitive, reversible inhibitors, and show remarkable selectivity for FAAH over the other components of the endocannabinoid system.

View Article and Find Full Text PDF

Nonspecific binding of anandamide to plastic exhibits many features that could be mistaken as biological processes, thereby representing an important source of conflicting data on the uptake and release of this lipophilic substance. Herein, we propose an improved method to assay anandamide transport, by using glass slides (i.e.

View Article and Find Full Text PDF

The cellular uptake and the intracellular synthesis/degradation of anandamide are crucial steps for controlling its extracellular level and the duration of its activity. Although the biosynthesis and breakdown of anandamide are well understood, little is known about the mechanisms underlying its intracellular transport. Here, we investigated the presence of a potential carrier-mediated trafficking of anandamide within the cytosol, using a biotinylated analog as a tool to catch by affinity chromatography anandamide-interacting proteins.

View Article and Find Full Text PDF

The family of endocannabinoids contains several polyunsaturated fatty acid amides such as anandamide (AEA), but also esters such as 2-arachidonoylglycerol (2-AG). These compounds are the main endogenous agonists of cannabinoid receptors, able to mimic several pharmacological effects of Delta9-tetrahydrocannabinol (Delta9-THC), the active principle of Cannabis sativa preparations like hashish and marijuana. The activity of AEA at its receptors is limited by cellular uptake, through a putative membrane transporter, followed by intracellular degradation by fatty acid amide hydrolase (FAAH).

View Article and Find Full Text PDF
Article Synopsis
  • Anandamide (AEA) is a natural compound that interacts with certain receptors in our body, but how it's transported is still not fully understood.
  • Researchers created a modified version of AEA called b-AEA, which behaves similarly to AEA inside cells.
  • b-AEA doesn't mess with other parts of the endocannabinoid system, making it a helpful tool for studying how AEA moves and works in cells.
View Article and Find Full Text PDF

Type-1 (CB1) and type-2 (CB2) cannabinoid receptors belong to the rhodopsin family of G protein-coupled receptors, and are activated by endogenous lipids termed "endocannabinoids". Recent reports have demonstrated that CB1R, unlike CB2R and other receptors and metabolic enzymes of endocannabinoids, functions in the context of lipid rafts, i.e.

View Article and Find Full Text PDF

Purpose: To evaluate whether high intraocular pressure (IOP)-induced ischemia is associated with modifications in the retinal endocannabinoid metabolism and to ascertain whether drugs that interfere with the endocannabinoid system may prevent retinal damage due to ischemic insult.

Methods: Anandamide (AEA) synthesis, transport, hydrolysis, and AEA endogenous levels were assessed by means of high-performance liquid chromatography in the retinas of rats undergoing 45 minutes of ischemia followed by 12 hours of reperfusion. Under these experimental conditions, binding to cannabinoid (CB1R) and vanilloid (TRPV1) receptor was assessed with rapid-filtration assays.

View Article and Find Full Text PDF